Elzbieta Dworakowski

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. pmc Vitamin d: are we ready to supplement for breast cancer prevention and treatment?
    Katherine D Crew
    Department of Medicine, Division of Hematology Oncology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA
    ISRN Oncol 2013:483687. 2013
  2. pmc Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer
    Katherine D Crew
    Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Ave, 10 1072, New York, NY 10032, USA
    Cancer Prev Res (Phila) 5:1144-54. 2012
  3. ncbi request reprint Aspirin and NSAIDs: effects in breast and ovarian cancers
    Katherine D Crew
    Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
    Curr Opin Obstet Gynecol 18:71-5. 2006
  4. pmc Association between plasma 25-hydroxyvitamin D and breast cancer risk
    Katherine D Crew
    Department of Medicine, Division of Hematology Oncology, Columbia University, New York, New York 10032, USA
    Cancer Prev Res (Phila) 2:598-604. 2009
  5. ncbi request reprint Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk
    Katherine D Crew
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Avenue, 10 1072, New York, NY 10032, USA
    Carcinogenesis 28:2548-51. 2007
  6. ncbi request reprint Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk
    Katherine D Crew
    Department of Epidemiology, Mailman School of Public Health, Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
    Cancer Epidemiol Biomarkers Prev 16:2033-41. 2007
  7. pmc Rapid cortical bone loss in patients with chronic kidney disease
    Thomas L Nickolas
    Columbia University Medical Center, Department of Medicine, Division of Nephrology, New York, NY, USA
    J Bone Miner Res 28:1811-20. 2013
  8. pmc Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women
    Aline G Costa
    630 West 168th Street, PH8 West 864, New York, New York 10032
    J Clin Endocrinol Metab 98:4736-43. 2013
  9. pmc Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women
    Emily M Stein
    Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Bone Miner Res 28:1029-40. 2013
  10. ncbi request reprint PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism
    Mishaela R Rubin
    Department of Medicine, Division of Endocrinology, Metabolic Bone Diseases Unit, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Bone Miner Res 26:2727-36. 2011

Collaborators

Detail Information

Publications13

  1. pmc Vitamin d: are we ready to supplement for breast cancer prevention and treatment?
    Katherine D Crew
    Department of Medicine, Division of Hematology Oncology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA
    ISRN Oncol 2013:483687. 2013
    ..Despite compelling data from experimental and observational studies, there is still insufficient data from clinical trials to make recommendations for vitamin D supplementation for breast cancer prevention or treatment...
  2. pmc Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer
    Katherine D Crew
    Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Ave, 10 1072, New York, NY 10032, USA
    Cancer Prev Res (Phila) 5:1144-54. 2012
    ..This study highlights the importance of assessing toxicity for any chemopreventive agent being developed for chronic use in healthy individuals...
  3. ncbi request reprint Aspirin and NSAIDs: effects in breast and ovarian cancers
    Katherine D Crew
    Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
    Curr Opin Obstet Gynecol 18:71-5. 2006
    ..Specifically, this review will provide evidence for the chemoprevention of breast and ovarian cancers with analgesics, such as aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and acetaminophen...
  4. pmc Association between plasma 25-hydroxyvitamin D and breast cancer risk
    Katherine D Crew
    Department of Medicine, Division of Hematology Oncology, Columbia University, New York, New York 10032, USA
    Cancer Prev Res (Phila) 2:598-604. 2009
    ..Well-designed clinical trials are urgently needed to determine whether vitamin D supplementation is effective for breast cancer chemoprevention...
  5. ncbi request reprint Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk
    Katherine D Crew
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Avenue, 10 1072, New York, NY 10032, USA
    Carcinogenesis 28:2548-51. 2007
    ..Overall, this study suggests that the risk of breast cancer may be elevated among women with polymorphisms in the FAS gene and detectable PAH-DNA adducts...
  6. ncbi request reprint Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk
    Katherine D Crew
    Department of Epidemiology, Mailman School of Public Health, Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
    Cancer Epidemiol Biomarkers Prev 16:2033-41. 2007
    ..Overall, this study suggests that the risk of breast cancer may be elevated among women with polymorphisms in NER pathway genes and detectable PAH-DNA adducts...
  7. pmc Rapid cortical bone loss in patients with chronic kidney disease
    Thomas L Nickolas
    Columbia University Medical Center, Department of Medicine, Division of Nephrology, New York, NY, USA
    J Bone Miner Res 28:1811-20. 2013
    ..Future investigations are required to determine whether these cortical losses can be attenuated by treatments that reduce PTH levels and remodeling rates. ..
  8. pmc Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women
    Aline G Costa
    630 West 168th Street, PH8 West 864, New York, New York 10032
    J Clin Endocrinol Metab 98:4736-43. 2013
    ..Chinese-American women have bone microarchitectural features that confer greater bone stiffness compared to white women, but the physiology underlying these findings has not been investigated...
  9. pmc Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women
    Emily M Stein
    Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Bone Miner Res 28:1029-40. 2013
    ..These results provide evidence that in PHPT, microstructural abnormalities are pervasive and not limited to the cortical compartment, which may help to account for increased global fracture risk in PHPT...
  10. ncbi request reprint PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism
    Mishaela R Rubin
    Department of Medicine, Division of Endocrinology, Metabolic Bone Diseases Unit, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Bone Miner Res 26:2727-36. 2011
    ..These changes suggest that PTH(1-84) improves abnormal skeletal properties in hypoparathyroidism and restores bone metabolism toward normal euparathyroid levels...
  11. pmc Discriminants of prevalent fractures in chronic kidney disease
    Thomas L Nickolas
    Department of Medicine, Divisions of Nephrology, Columbia University Medical Center, New York, New York, USA
    J Am Soc Nephrol 22:1560-72. 2011
    ..In summary, these cross-sectional data suggest that measurement of bone turnover markers may increase the diagnostic accuracy of densitometry to identify patients with CKD at high risk for fracture...
  12. pmc Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration
    Mami Ogita
    Department of Medicine, Columbia University, New York, New York 10032, USA
    Endocrinology 149:5713-23. 2008
    ..Estrogens promote proliferation of early osteoblast progenitors but inhibit their differentiation by osteogenic agents such as PTH or BMP-2...